Two peer-reviewed publications show that the Myriad Women’sHealth NIPS solution, Prequel Carrier Screen, is accurate across all types of patients,including patients known to have lower fetal fractions due to high BMI. (Seelinks below to download both peer-reviewed publications.)
A cohort of 58,105 was sought to confirm Prequel CarrierScreen’s effectiveness. This study also included difficult-to-call samples suchas vanishing twins and mosaicism, as well as consanguineous, ovum donor, andsurrogate pregnancies. Results were delivered to 99.9% of patients whilemaintaining high sensitivity and specificity. Across the entire cohort, therewere seven false negatives.
In the past, patients have been turned away from NIPSbecause of their ethnicity and body habitus. However, with Prequel PrenatalScreen, they can receive an accurate and reliable result the first time. By choosingPrequel Prenatal Screen, you can now deliver superior patient care regardlessof body habitus, race, or ethnicity.
Download the peer-reviewed publications by clicking below.
March 17, 2021
NAVIGATING YOUR BREAST AND OVARIAN HEALTH IN THE (NEVER-ENDING) ERA OF COVID
It has been almost a year since most of us found ourselves in the completely unchartered territory of “sheltering in…Read more about NAVIGATING YOUR BREAST AND OVARIAN HEALTH IN THE (NEVER-ENDING) ERA OF COVID
February 25, 2021
I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier
This Sunday, February 28th, is #RareDiseaseDay! To raise awareness and support for the rare disease community, Myriad Women’s Health partnered…Read more about I Am Glad to Know: The Importance of Carrier Screening Through the Voice of a Carrier
December 23, 2020
Myriad’s 7 Greatest Hits in 2020
Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access…Read more about Myriad’s 7 Greatest Hits in 2020